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antigen (HBsAg) in HBsAg carriers in a follow-up
community studyTo the Editor,
Readers raised valuable comments to our manuscript
entitled “Changing serum levels of quantitative hepatitis B
surface antigen (HBsAg) and hepatitis B virus DNA in hep-
atitis B virus surface antigen carriers: A follow-up study of
an elderly cohort”, which was published in the Kaohsiung
Journal of Medical Sciences [1]. This is a community-based
study in a hepatitis B, C, and D virus (HBV, HCV, and HDV,
respectively) endemic area. In the initial screening in 1997,
2909 (30.2% of the whole population in the township) adults
aged  45 years [2,3] were enrolled. Among them, only 222
(7.6%) were hepatitis B surface antigen-positive
[HBsAg(þ)], anti-HCV(), and anti-HDV(). Thirteen years
later (2010), 59 of these 222 individuals (26.6%) responded
to this follow-up study. The small sample size is one of the
limitations of this study. It should be noted that sample size
depends on the prevalence of diseases and the response
rate of study participants. It is also more difficult to
conduct such a long-term follow-up study for older pop-
ulations. However, this type of study provided better
community-based information compared with a well-known
hospital-based study. In a small part of our previous study
in this population [3], 23 of 25 (92%) individuals were ge-
notype B and only two (8%) were genotype C. Using this
proportion, only about five individuals were genotype C
among these 59 chronic hepatitis B patients. Having only
five cases should not result in any conclusion. For cost-
ebenefit consideration, we did not include the expensive
genotype test in this study. Meanwhile, the contribution of
genotype in HBsAg is still controversial. Although the
secretion of HBsAg might be strongly influenced by HBV
genotype [4], the previous study also indicated that HBV
genotype B or C was not associated with HBsAg clearance inConflicts of interest: All authors declare no conflicts of interest.
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1607-551X/Copyright ª 2015, Kaohsiung Medical University. PublishedHBeAg-negative patients [5]. As mentioned above, this was
a community-based study, and the study participants had
only a mild liver disease. In our study cohort, all 59 patients
were diagnosed by ultrasound to have parenchymal liver
disease or fatty liver disease in 2005. Only two cases pro-
gressed to liver cirrhosis in 2010; both were in the high
HBsAg and high HBV DNA (HsHD) groups persistently.
Moreover, none of the patients developed hepatocellular
carcinoma (HCC) during follow-up. Therefore, advanced
liver diseases such as cirrhosis or HCC were not main the
concern of the HBsAg decrease in our study.
We emphasized that this community-based study pro-
vided clinical information from asymptomatic residents.
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